Litcius/Paper detail

Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients

Sharon Amit, Gili Regev‐Yochay, Arnon Afek, Yitshak Kreiss, Eyal Leshem

2021The Lancet351 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyMedicineCoronavirus InfectionsInfectious disease (medical specialty)OutbreakInternal medicineDiseaseSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyViral gastroenteritis research and epidemiology
Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients | Litcius